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Introduction 
The afferent innervation of the gastrointestinal (GI) tract consists of intrinsic and extrinsic 
sensory neurons that respond to nutrients, chemicals or mechanical stimuli within the 
gut lumen.  Most stimuli do not interact directly with the afferent nerves but instead 
activate specialised cells in the epithelium in a process of sensory transduction.  It is 
thought that one of the first steps in this process is the release of serotonin (5-HT) from 
the enterochromaffin (EC) cells (for reviews on the sensory transduction process, see 
Raybould, 2002; Bertrand, 2003; Blackshaw et al., 2007; Gershon & Tack, 2007; Grundy, 
2008).  The EC cells are a sub-type of enteroendocrine (EE) cells which are found 
among the enterocytes of the intestinal epithelium.  The EC cells are responsible for the 
production and storage of the largest pool of 5-HT in the body (Erspamer, 1954; 
Gershon & Tack, 2007).  Released 5-HT can act on the intrinsic nerves (reviewed by 
Schemann, this issue) and vagal endings (reviewed by Zagorodnyuk et al, this issue).  
This review will focus on the role of 5-HT in sensory transduction and examine how the 
EC cell produces and releases 5-HT.  We will explore recent developments that have 
helped to elucidate some of the proteins that allow EC cells to sense the luminal 
environment.  Finally, we will highlight some of the findings from new studies using 
electrochemical techniques which allow the real-time recording of 5-HT concentrations 
near to the EC cell.    
 
5-HT is an important paracrine signalling substance in the GI tract 
Serotonergic transmission from the raphé nuclei acts on most brain areas while enteric 
neurons utilise 5-HT for some reflexes and synaptic potentials (e.g., Monro et al., 2002; 
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Monro et al., 2005).  It is, however, the non-neuronal EC cells that produce, store and 
release the largest pool of 5-HT in the body (Erspamer, 1954; Gershon & Tack, 2007).  
5-HT released from the EC cells modulates a large number of GI reflexes in health and 
disease (for reviews see Furness et al., 1999; Kirkup et al., 2001; Bertrand, 2003; 
Grundy & Schemann, 2005).  5-HT and other EE cell mediators, such as cholecystokinin 
(CCK) or adenosine-5'-triphosphate (ATP), are thought to act in concert to initiate or 
maintain motor and secretory patterns tuned to the contents and to the region of 
intestine.  For example, mechanical stimuli applied to the mucosal epithelium releases 
5-HT into the lumen which enhances peristaltic reflexes (e.g., Bülbring & Crema, 1959; 
Kirchgessner et al., 1992; Foxx-Orenstein et al., 1996; Grider et al., 1996; Linden et al., 
2003; O'Hara et al., 2004). Similarly, nutrients - such as short or long chain fatty acids, 
peptides, glucose - or chemical stimuli (e.g., acid, base) seem to act at the epithelial 
border by causing release of 5-HT from the EC cells or other sensory mediators from the 
EE cells (Raybould, 2002; Bertrand, 2003; Blackshaw et al., 2007; Gershon & Tack, 
2007; Grundy, 2008). 
 
<Figure 01> 
 
The release of 5-HT from the EC cells is not always beneficial.  A very high level of 
release is one of the main causes of symptoms such as the diarrhoea associated with 
cholera (Lundgren, 1998; Turvill et al., 2000), the nausea due to chemo- or radiation 
therapy (Sanger, 1990) or the flushing and heart palpitations associated with carcinoid 
tumours (McCormick, 2002).  The central position of EC cells in these symptoms has led 
to the proposal that they contribute to similar problems associated with chronic intestinal 
diseases such as inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS).  
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This has led to a great deal of interest in the effects of inflammation on EC cells and the 
5-HT they release (e.g., Lomax et al., 2006; Mawe et al., 2006; Keating et al., 2008).  
Interestingly, it is not always clear from individual measures of 5-HT levels or EC cell 
numbers if the overall availability of 5-HT goes up or down in such cases.  For example, 
in early studies of ulcerative colitis (UC) patients, the numbers of EC cells decreased 
(e.g., Verity et al., 1962), while in later studies the numbers of EC cells increased (e.g., 
El-Salhy et al., 1997).  More recently, Coates et al (2004) have found that the number of 
EC cells decreased in patients with severe UC but found no change in mild UC or in 
tissues from irritable bowel syndrome (IBS) patients.  In contrast, Dunlop et al found an 
increase in mucosal 5-HT turnover in post-infectious IBS (Dunlop et al., 2005). 
 
Animal models of inflamed bowel have also yielded conflicting results.  In a 
trinitrobenzene sulfonic acid (TNBS) model of mouse colitis, Linden et al (2005a) 
showed increased 5-HT availability due to a decrease in serotonin reuptake transporter 
(SERT)-dependent 5-HT uptake with no change in EC cell numbers, while previous 
studies of TNBS models of guinea-pig colitis and ileitis found an increase in EC cell 
numbers (Linden et al., 2003; O'Hara et al., 2004).  On the other hand, a consistent 
finding of these studies was that levels of SERT expression were decreased.  The 
central role of SERT in controlling 5-HT availability is highlighted in a new study by 
Bischoff et al showing that rats lacking SERT have a much more severe TNBS induced 
colitis (Bischoff et al., 2009).  
 
Several recent studies have explored the immunological link between inflammation and 
5-HT availability.  Wang et al have shown that during parasitic infection a Th2-based 
mechanism causes an increase in the number of EC cells and the amount of 5-HT 
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(Wang et al., 2007).  In support of this, Motomura et al have shown that a Th2-mediated 
inflammation causes similar changes as compared to a Th1 mediated inflammatory 
response to the same parasitic infection (Motomura et al., 2008).  Taken together these 
studies show that disease state such as inflammation can strongly regulate 5-HT 
availability.  
 
The production, release, uptake and degradation of 5-HT in the 
intestine 
The EC cells produce 5-HT from the dietary amino acid L-tryptophan using the rate 
limiting enzyme tryptophan hydroxylase (TpH) (Verbeuren, 1989). In the gastrointestinal 
tract TpH isoform 1 has been localized to EC cells (Yu et al., 1999) while the second 
isoform, TpH2, has been localized to enteric neurons and central raphé neurons 
(Walther et al., 2003).  TpH1 converts L-tryptophan to 5-hydroxytryptophan (5-HTP).  
The non-rate limiting enzyme L-amino acid decarboxylase (L-AADC), contained in EC 
cells, then converts 5-HTP to 5-HT (Hakanson et al., 1970; Verbeuren, 1989).  Newly 
produced 5-HT is packaged into granules/vesicles by the vesicular monoamine 
transporter 1 (VMAT1); this isoform is specific for EC cells and a small proportion of 
adrenal chromaffin cells (Rindi et al., 2004; Schafermeyer et al., 2004).  5-HT is released 
mainly from the granules stored near the basal border of the EC cell, but some studies 
have also identified granules near the apical membrane (Nilsson et al., 1987) and 
demonstrated that 5-HT can be selectively released into the lumen (Ahlman et al., 1981; 
Forsberg & Miller, 1982; Fujimiya et al., 1998b) and found in the faeces (Fukumoto et al., 
2003; Tsukamoto et al., 2007).  What causes the release of 5-HT will be covered in detail 
in later sections of this review. 
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<Figure 02> 
 
5-HT released from the granules stored near the basal border of the EC cell enters the 
lamina propria where it can interact with nerve terminals, immune cells and can be taken 
up into the blood by the platelets.  The EC cells are in constant migration from the crypt 
to the tip of the villus (e.g., O'Hara & Sharkey, 2007); one consequence of this is that no 
close contacts with nerve terminals or immune cells can be maintained.  Indeed close 
contacts between EC cells and other structures are not common in the first place (Wade 
& Westfall, 1985).  Thus to affect the nerve terminals, 5-HT must be released in a 
paracrine manner.  The high concentrations of 5-HT released from the EC cell can 
activate the intrinsic or extrinsic sensory nerve terminals via 5-HT3 receptors (Hillsley et 
al., 1998; Bertrand et al., 2000), while at lower concentrations it activates 5-HT4 or 
5-HT1P receptors (Grider et al., 1996; Pan & Gershon, 2000).  Many in vitro studies have 
shown that these receptors are important for the initiation or propagation of enteric 
reflexes such as peristalsis (Kadowaki et al., 1996; Tuladhar et al., 1997; Grider et al., 
1998; Jin et al., 1999) or secretion (Sidhu & Cooke, 1995; Cooke et al., 1997a, b). 
 
The actions of 5-HT are terminated by uptake via the serotonin re-uptake transporter 
(SERT - a Na+/Cl- dependent transporter) into epithelial cells (Martel et al., 2003).  This 
is the same SERT protein that is found in platelets, enteric neurons and central raphé 
neurons (Gershon, 2004).  SERT is the target for important therapeutic drugs such as 
fluoxetine and paroxetine, members of the serotonin-selective re-uptake inhibitor family.  
SERT has been localized to many intestinal epithelial cells using immunohistochemistry 
(Wade et al., 1996) and northern blot analysis (Chen et al., 1998), and appears to be 
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present in the apical and basal membranes of the epithelial cell (Gill et al., 2008).  The 
SERT gene is subject to a number of naturally occurring polymorphisms in the coding 
and promoter regions, some of which have been linked to the symptoms of Irritable 
Bowel Syndrome (IBS) (e.g., Yeo et al., 2004) or to the pharmacogenomics of IBS 
treatment (Camilleri et al., 2002; Scherl & Frissora, 2003).  A novel splice variant of 
SERT has been identified that is specific for the intestinal epithelium (Linden et al., 
2005b; Linden et al., 2009) but has yet to be linked to disease.   
 
Once SERT has brought 5-HT into the epithelial cells it is degraded to 5-
hydroxyindoleacetic acid (5-HIAA) by monoamine oxidase A (MAOA), an enzyme 
localised to all epithelial cells of the intestine (Egashira & Waddell, 1984; Rodriguez et 
al., 2001).   Alternatively, 5-HT released into the lamina propria may enter the portal 
circulation and be found either as free 5-HT or within platelets (via the actions of SERT).  
As the portal circulation is processed by the liver the free 5-HT is rapidly degraded by 
liver enzymes.  About one third is degraded by MAOA to 5-HIAA which is commonly 
detected in urine.  The remaining two thirds of 5-HT is degraded to the metabolite 
5-HT-O-glucuronide (Gershon et al., 1989; Verbeuren, 1989).  Importantly, 5-HT taken 
up by platelets is protected from degradation in the liver and enters the general 
circulation. 
 
<Figure 03> 
 
Co-storage of other bioactive compounds in EC cells 
5-HT is co-stored in the EC cells with a variety of other paracrine/hormone substances.   
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EC cells contain the vesicle storage protein chromogranin A (CGA); CGA is also 
expressed in most of the other enteroendocrine cells (Facer et al., 1985; Rindi et al., 
2004).  Once VMAT1 has transported 5-HT into the vesicle, CGA is thought to bind to it 
allowing high concentrations of 5-HT to be stored inside the granules, as has been 
demonstrated for adrenaline in chromaffin cells (Montesinos et al., 2008).  The presence 
of CGA allows EC cells to be identified using a silver reaction, a process which is still in 
use today (Grimelius, 2004).  Interestingly, CGA can also be released with 5-HT 
(Okumiya & Fujimiya, 1999) and may be cleaved into an active hormone form (Curry et 
al., 2002), though the physiological relevance for this in the intestine has not been 
established.  Of the additional substances contained in EC cells, perhaps most important 
is melatonin.  5-HT is a precursor for melatonin synthesis and many EC cells have been 
shown to contain melatonin (Bubenik, 2002) and to release it to cause physiological 
effects (Sjöblom & Flemström, 2003).  Another interesting transmitter contained in EC 
cells is gamma-aminobutyric acid (GABA).  Of the epithelial cell types, GABA is present 
only in the EC cells (Oomori et al., 1992) and as such it has been used as a marker to 
help in the enrichment of EC cell cultures (Schafermeyer et al., 2004).  It also seems 
likely that ATP, or a related purine, is co-stored with 5-HT.  Recently discovery of 
vesicular nucleotide transporter (Sawada et al., 2008), which transports ATP into 
vesicles, should allow definitive studies on this matter. 
 
There are a variety of other substances that are in EC cells but have an unclear 
physiological role or were originally thought to be in EC cells but were later shown not to 
be.  The relatively newly discovered gut hormone uroguanylin is present in all EC cells 
(Perkins et al., 1997) while the related peptide guanylin was originally proposed to be in 
EC cells (Cetin et al., 1994), but further study showed this was due to the guanylin 
antibody cross-reacting with uroguanylin (Perkins et al., 1997).  EC cells have also been 
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shown to contain the opioid precursor dynorphin (Cetin, 1988).  Motilin was proposed to 
be contained in EC cells (Pearse et al., 1974) but later research suggests this is not the 
case (Forssmann et al., 1976; Fujimiya et al., 1998a). Substance P was initially reported 
to be in some EC cells (Heitz et al., 1976), however, later studies either found only a 
small amount (Alumets et al., 1977) or none (Sokolski & Lechago, 1984).  The story of 
substance P is still unclear as it has again been reported to be released from EC cells 
(Simon et al., 1992), and a posthumous review of the work of Vittorio Erspamer suggests 
that it is stored in the EC cells of some species and in some EC cell derived tumours 
(Severini et al., 2002; Grundy, 2008). 
 
EC cell transduction machinery 
There are two ways that stimuli in the intestinal lumen may be detected by the afferent 
nerve terminals located in the lamina propria.  First, they may be ferried across the 
epithelium by specific transport proteins, as are most nutrients once they are broken 
down.  Once across, these stimuli could interact with specialised receptors on the nerve 
terminal.  This is the mechanism hypothesised by Liu et al (1999) for glucose and it is 
clear that capsaicin directly activates afferents through TRPV1 receptors.  Second, 
receptors and transduction machinery may exist on the luminal aspect of EE cells or 
other specialised cells within the mucosal epithelium.  The sensory mediators these cells 
release are known to act on receptors on the afferent terminals (Blackshaw et al., 2007).   
As alluded to previously in this review, this is the sensory transduction process which we 
believe most stimulants act through.    
 
In support of this second mechanism, there is evidence for taste transduction machinery 
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on intestinal epithelial cells.  The presence of the taste G-protein α-gustducin has 
recently been shown in some EE cells (Hass et al., 2007; Sutherland et al., 2007).  
Similarly, sub-sets of EE cells (including EC cells) have been shown to contain taste 
receptors (T1R and T2R), second messenger systems (PLCβ2) and channels (TRPM5) 
that form part of the taste transduction machinery normally associated with the tongue 
(Dyer et al., 2005; Bezençon et al., 2007; Sutherland et al., 2007; Kidd et al., 2008; 
Mace et al., 2009; Young et al., 2009).  Recently, Nozawa et al (2009) have shown that 
TRPA1, the receptor for pungent compounds such as mustard, is also expressed by EC 
cells.  A good review of this very active area of research is Rozengurt and Sternini 
(2007).   
 
The evidence for functional transduction machinery of the other senses in the GI tract is 
not as convincing as that for taste.  Hofer et al (1999) showed that the G-protein 
transducin, present in the eye and in some taste receptors, was also present in GI 
epithelium.  More recently, Mace et al have confirmed this and have shown that 
transducin can couple to taste machinery (Mace et al., 2009).  A recent study by Braun 
et al has shown that some of the smell machinery is present in the gastrointestinal tract 
(Braun et al., 2007).  In particular, a subset of olfactory receptors was detected, a finding 
that was supported by Kidd et al who showed that activation of these receptors 
stimulated 5-HT release from EC cells (Kidd et al., 2008). 
 
Glucose sensing in the GI tract is apparently more complicated than for other nutrients.  
It has been linked to taste receptors (Mace et al., 2009) but it has also been linked with 
the mechanisms of glucose sensing used by the pancreatic β-cells (Raybould, 2002; 
Raybould et al., 2004).  Thus far, KATP (Kirchgessner et al., 1996), Na
+/glucose 
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co-transporter 1 (SGLT1) (Liu et al., 1999; Kidd et al., 2008) and glucose transporter 2 
(GLUT2) (Mace et al., 2007) have all been found to play roles.  For a short review of the 
glucose sensing machinery in the GI tract, please see Dyer et al (2007).   
 
5-HT release from the EC cell 
Much of the mechanistic data on how EC cells work has come from Racké, Schwörer 
and colleagues who over the years have described 5-HT overflow from in vitro segments 
of intestine from a variety of small and large animals (for review, see Racké et al., 1996). 
They found that 5-HT release is generally via an external Ca++-dependent process 
utilising L-type calcium channels (Forsberg & Miller, 1983).  However, upon muscarinic 
receptor activation 5-HT release can occur by utilising calcium from internal stores.  
Release of 5-HT can also be evoked by agonists at a variety of receptors such as 
adrenoceptors, muscarinic receptors or 5-HT3 autoreceptors, while release can be 
inhibited by activation of GABAA, nicotinic or somatostatin (SST) 2 receptors or 5-HT4 
autoreceptors (Gebauer et al., 1993).  
 
The 5-HT measured using these traditional overflow methods is the sum of the output of 
many EC cells measured many minutes after release has occurred and is far from the 
site of action; thus, temporal and spatial information is lost.  It is not surprising then that 
other techniques have been used in an attempt to look at the activity of only a few EC 
cells at a time.  Studies of calcium transients in small numbers of EC cells show clearly 
that apparently identical EC cells respond to transmitter or calcium channel agonist 
differently (Satoh et al., 1995; Lomax et al., 1999; Satoh et al., 1999); although for the 
most part the pharmacological features found by Racké and Schwörer have been 
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supported.   
 
Studying single EC cells in vitro has been difficult as they are a relatively small 
proportion of the epithelial cells, perhaps 1 - 3% in human (Bose et al., 2000; Coates et 
al., 2004).  In addition, there are many other types of EE cells with similar structural 
properties (Wade & Westfall, 1985).  A successful approach at enriching the EC cells 
has used techniques originally developed for the histamine containing EC-like cells of 
the stomach (Oh et al., 2005).  Using successive sucrose gradients, Schafermeyer et al 
were able to enrich the EC cell fraction (Schafermeyer et al., 2004) and more recently 
this technique has been used by Doihara et al (2009).  Kidd et al have succeeded in 
enriching the EC cells using fluorescence-activated cell sorting techniques to the point 
that gene chips could be used to show expression of some taste machinery mRNA (Kidd 
et al., 2006; Modlin et al., 2006; Kidd et al., 2008).  Finally, Braun et al have purified 
human EC cells isolated by laser micro-dissection (Braun et al., 2007). 
 
A further attempt to look at single cells has utilised an EC cell model, the BON cell, 
which is derived from a metastatic human carcinoid tumour of the pancreas (Evers et al., 
1994).  BON cells have been used as a model of EC cell function (Christofi et al., 2004; 
Tran et al., 2004) and to investigate the release of 5-HT by D-glucose application or 
mechanical stimulation (Kim et al., 2001a; Kim et al., 2001b).  Recent studies have 
questioned the value of the BON cell as an EC cell model (Siddique et al., 2009) and 
have instead used a cell line derived from a human carcinoid tumour of the small 
intestine (KRJ-I) (Kidd et al., 2008).  Other models include a human pancreatic 
endocrine cell line (QGP-1) (Doihara et al., 2009) and a rat pancreatic delta cell line 
(RIN14B) (Nozawa et al., 2009).  Finally, there is the potential for a promising new model 
of the EC cell from work being done using the 'immortoMouse' (Whitehead & Robinson, 
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2009). 
 
 
Electrochemical detection of 5-HT release 
Another successful approach to examining only a few EC cells at a time has been to use 
electrochemical techniques to record 5-HT levels near the EC cells in real time.  These 
techniques have been commonly used to record, for example, adrenaline release from 
chromaffin cells (Chow et al., 1992), dopamine release from the caudate nucleus, 
noradrenaline release from the thalamus (Gerhardt et al., 1984) and 5-HT from the 
raphé nucleus (Daws et al., 2005).  When molecules of a transmitter such as 5-HT are 
oxidised the transfer of electrons can be detected and quantified.  This provides a direct 
and accurate measure of the number of molecules (i.e., the concentration) at the 
electrode tip (e.g., see Benzekhroufa et al., 2009).  Generally carbon fibre electrodes 
have been used, but boron-doped diamond-coated platinum electrodes have also been 
used successfully (Bian et al., 2007; Patel et al., 2007).  
 
In the GI tract electrochemical techniques have been used to record 5-HT release 
selectively and quantitatively.  Steady state levels of 5-HT near the mucosal surface 
have been measured and mechanically evoked 5-HT release has been determined.  The 
function of SERT and its contribution to the endogenous 5-HT signal can also be 
measured.  Together, these data allow the availability of 5-HT in healthy GI tissues to be 
assessed in real time and compared with that in diseased tissues.  As these 
electrochemical techniques are relatively new in the GI field it is worth reviewing some of 
the evidence supporting its utility in detecting 5-HT released from EC cells. 
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Is 5-HT detected selectively by electrochemical techniques? 
Given the number of substances that are contained in EC cells, and in other EE cells, it 
is important to know that 5-HT can be detected selectively using electrochemical 
techniques.  One way to determine if compounds other than 5-HT are present and will 
contribute to the oxidation current recorded is to use cyclic voltametric techniques.  
Cyclic voltammetry ramps the voltage at the electrode while recording the current.  5-HT 
starts to oxidise at a specific voltage (usually around +300 mV) and when the voltage 
ramp reaches this potential much of the 5-HT on the electrode surface will oxidise 
producing a clear peak in the oxidation current.  Another way to ensure that 5-HT is 
detected selectively is to coat the electrode with a thin film of Nafion, an anionic 
exchange resin that repels anionic species such as ascorbic acid or the metabolite 
5-HIAA, and attracts the cationic 5-HT.   
 
<Figure 04> 
 
In each species tested to date, it has been shown that 5-HT is the major peak at lower 
oxidation potentials (< +500 mV).  5-HT peaks have been observed from the ileal 
mucosa of guinea pig (Bertrand, 2004), rat (Bertrand et al., 2008c) and mouse 
(Bertrand, 2006b) and the colon of mouse (Bertrand et al., 2008e).  The catechols or 
dopamine oxidise at a lower potential than 5-HT but have not been observed during 
recordings made near the mucosa.  As the voltage is ramped to around +700 mV a 
second peak is often observed from the mucosa.  It could be that the signal is due to 
melatonin which can also be released from the EC cells.  In support of this, the second 
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peak mirrors the 5-HT time course including run down, and exogenous melatonin 
oxidises at the same potential as the second peak seen from the mucosa (Bertrand, 
2004).  Recent preliminary work has confirmed that melatonin is released during 
electrochemical experiments (Patel, 2008) and has shown that the level of endogenous 
melatonin at the mucosal surface is increased in aged mice (P. Bertrand, unpublished 
data).  As melatonin treatment has been shown to improve age-related changes in gall-
bladder (Gomez-Pinilla et al., 2006), the role of endogenous melatonin in gastrointestinal 
function may be a ripe new area of research.  
 
Can the concentration of 5-HT be determined near the EC cell? 
The concentration of 5-HT near the mucosal surface can be calculated based on the 
linear relationship between oxidation current and 5-HT concentration, using the current 
produced by known concentrations of exogenous 5-HT to calibrate this relationship.  It is 
worth highlighting the fact that the concentration of 5-HT detected depends on how close 
the electrode is to the site of release, the EC cell.  The minimum concentrations that can 
be detected away from the mucosa are less the 100 nM.  As the electrode is brought 
close to, or touching, the mucosal epithelium, 5-HT concentrations rise to over 1 M.  
Although the signal to noise ratio is very good, there are several problems and criticisms 
inherent in actually touching the epithelial surface with the electrode (see Vanden 
Berghe, 2008).  Other studies looking at adult and neonatal guinea pig ileum (Bian et al., 
2007; Patel et al., 2007) and at BON cells (Braun et al., 2007) have not routinely 
converted oxidation current to 5-HT concentration, so we can not directly compare with 
previous studies (e.g., Bertrand, 2004).   
 
<Figure 05> 
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What information do electrochemical recordings give?  
As this is a new technique in the GI tract, it is important to ask what electrochemical 
recordings can tell us about the role of serotonin.  Thus far electrochemical studies have 
measured steady state levels of 5-HT at the mucosal surface, and measured the kinetics 
of evoked 5-HT release following mechanical stimulation of the EC cells.  5-HT levels 
have been measured near the mucosal surface from a variety of animals (Bertrand, 
2004, 2006b; Bian et al., 2007; Patel et al., 2007; Bertrand et al., 2008a; Bertrand et al., 
2008c) and human surgical specimens (Bertrand et al., 2008b). 
 
<Figure 06> 
 
Steady state levels of 5-HT detected electrochemically reflect the amount of 5-HT that is 
trapped in the unstirred layer.  This level of 5-HT represents a steady state between 
escape into the bulk solution (the lumen) and reuptake by SERT into the epithelial cells 
(more about SERT below).  As an example, the steady state levels of 5-HT in mouse 
colon are about 2 M, lower than that found in the mouse ileum (Bertrand, 2006b) or in 
the ileum of other species such as rat (Bertrand et al., 2008c) or guinea-pig (Bertrand, 
2004) and similar to known distributions of EC cells (Sjölund et al., 1983).   
 
Mechanical compression of the epithelium is a challenge to the EC cell and so the 
mechanosensory function of the EC cell can be tested.  When a glass rod  (Bian et al., 
2007) or the electrode itself (Bertrand et al., 2008c) is used to stimulate the EC cells an 
increase in the levels of 5-HT are detected.  In addition, a contraction of the circular or 
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longitudinal muscle is a mechanical stimulus for 5-HT release (Bertrand, 2006a).  The 
peak concentration of mechanically evoked 5-HT release is usually 2-4 times that of the 
steady state levels.  For example, peak levels of 5 HT released in mouse colon are 
approximately 7 M in response to compression of the mucosa versus 2 M at steady 
state (i.e., the steady state levels were approximately 30% of peak compression levels).  
In mouse ileum compression evoked 10 M peak 5-HT while steady state levels were 
6 M (Bertrand, 2006b). 
 
5-HT uptake by SERT can be detected electrochemically 
The actions of 5-HT in the GI tract are terminated by uptake via the SERT which is 
located in most epithelial cells (e.g., Gill et al., 2008).  As noted above, the levels of 5-HT 
reflect a steady state between escape into the luminal solution and transport by SERT 
into the enterocytes.  Using electrochemical techniques, it is possible to infer SERT 
function in real time from GI tissues.  Blockade of SERT with a reuptake inhibitor such as 
fluoxetine can increase peak levels of compression-evoked 5-HT release and can 
prolong the decay time of these responses.  Furthermore, there is an increase in steady 
state levels of 5-HT near the mucosa (Bian et al., 2007; Bertrand et al., 2008c) and an 
increase in the decay times of exogenously applied 5-HT (pressure ejected onto the 
surface of the mucosa) (Bertrand et al., 2008c).  In contrast, is seems that blockade of 
SERT does not increase the peak level of 5-HT detected following contraction-evoked 
release (Bertrand et al., 2008c).   
 
<Figure 07> 
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What can the electrochemical determination of 5-HT concentration tell us 
about receptor activation? 
Electrochemical methods allow the accurate measure of the absolute concentrations of 
5-HT near the mucosa and, by extension, near the afferent nerve terminals that control 
GI function and sensation (Keating et al., 2008).  The absolute concentration of 5-HT 
near the nerve terminal is important because this may substantially alter the activation or 
desensitization of serotonin receptors on afferent nerve terminals, or on the EC cells 
themselves.  For example, the peak concentration of 5-HT measured from mouse colon 
was approximately 7 M, high enough to activate the 5 HT3 receptor (Bertrand et al., 
2008a; Bertrand et al., 2008e).  The ligand-gated 5-HT3 receptor can only be activated 
by relatively high (> 1M) concentrations of 5-HT and to be exposed to these high 
concentrations, the receptor must be close to the site of 5-HT release.  Near the EC cell 
concentrations are high while far from the receptor concentrations are lower as a result 
of dilution and reuptake.  However, these lower concentrations of 5-HT are not inactive 
as all other 5-HT receptors are G-protein coupled requiring much lower (> 5 nM) 
concentrations of 5-HT for activation.  Thus, we can speculate that the actions of 5-HT 
through the clinically important 5-HT4 receptor could be far from the site of 5-HT release.   
 
Are electrochemical methods sensitive to changes in 5-HT availability 
during development or disease? 
Recent studies have used electrochemical techniques to explore the availability of 5-HT 
in animal models of development and disease.  Bian et al has shown that mechanically 
stimulated release of 5-HT is increased by blockade of SERT in adult but not neonatal 
guinea pig ileum (Bian et al., 2007).  This suggests that SERT levels are lower in 
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neonatal ileum, a finding that was supported with western blot analysis (Bian et al., 
2007).  The levels of 5-HT may increase during aging.  Preliminary data has shown a 
50% increase in 5-HT release from aged mice (21 months) compared to young mice (3-5 
months)(P. Bertrand unpublished observations).  Similarly, electrochemical determination 
of 5-HT availability has been seen to increase in a mouse model of inflammation 
(Bertrand et al., 2008a).  During DSS-colitis, the levels of 5-HT detected by 
electrochemical methods were almost doubled that found in inflamed tissues.    
 
It will be interesting to see how functional measures of 5-HT availability, such as the 
electrochemical methods described here, compare to anatomical or genetic analyses in 
a variety of disease states. Taken together, electrochemical determinations appear to be 
a useful adjunct to traditional methods of measuring 5-HT availability.  
  
How important is 5-HT to GI tract function? 
As this review is about 5-HT as a sensory mediator or paracrine substance it is fair to 
ask how important 5-HT is in the greater scheme of GI tract control.  It has been known 
for years that experimentally reducing 5-HT content in the GI tissues does not cause as 
dramatic a reduction in enteric reflexes as one might predict.  For example, Bülbring and 
Lin (1958) showed that 5-HT overflow dropped by 90% during sustained peristalsis but 
that fluid transport only dropped by 50%.  Adding the precursor 5-HTP increased 5-HT 
output but actually decreased fluid transport (Bülbring & Lin, 1958).  Similarly, depletion 
of EC cell 5-HT by parachlorophenylalanine (pCPA) (Weber, 1970) did not affect 
gastrointestinal transit of a charcoal meal (Pourgholami & Goshadrou, 1995).  Further, 
genetically reducing 5-HT availability does not cause death or a lack of GI function (Lrp5 
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over expression, Yadav et al., 2008), (knockout of TpH1, Walther et al., 2003).  
 
Putting aside the inherent dangers of using genetic models which allow developmental 
plasticity to occur, it is fair to say that a decrease in 5-HT availability does not cause 
severe long-term GI tract dysfunction.  There are several reasons why this may be the 
case.  First, as noted 5-HT is one of many GI hormones released from EE and EC cells.  
It is clear that these hormones have individual as well as overlapping functions; thus, 
they can act in concert and act as a backup.  Second, the GI tract is well known for its 
ability to adapt and change to the environment.  Unlike most organs of the body, the GI 
tract is subject to an ever-changing chemical environment.  Many of the toxins now used 
to block synaptic or neuromuscular transmission could well have been ingested 
accidentally by past generations (e.g., hyoscine/belladonna) and so the GI tract has 
developed to overcome the problem of ingested toxins.  Thus, while too much 5-HT can 
be toxic (e.g., following chemotherapy), it seems that with too little 5-HT life still goes on 
thanks to these alternative mechanisms.  Does this mean measuring 5-HT levels is not 
important for understanding the physiology or pathophysiology of the GI tract?  No, on 
the contrary it means that 5-HT is a useful marker for a variety of disease states.  The 
system of enzymes and transporters that produce and package 5-HT, and the EC cells 
and their host of proteins which control the release of 5-HT, are part of a highly 
adaptable system.  
 
Future directions 
Research on serotonin and EC cells in the GI tract has gained momentum in the last 10 
years.  We believe that some of the most exciting developments relate to the isolation 
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and genetic analyses of EC cells, and to the evoked release of 5-HT by a wide variety of 
stimulants with subsequent detection using electrochemical techniques. 
 
The enrichment of EC cells has now been accomplished by several groups using 
centrifugation, cell sorting and laser micro-dissection.  In addition, several new cell lines 
have been characterised and are as good as, if not better than, the venerable BON cell 
line.  The final step may be to generate a transgenic mouse with EC cell-specific 
expression of a fluorescent protein, as has been done with GLP containing L-cells 
(Reimann et al., 2008) and CCK cells (Samuel et al., 2008).  The enrichment of EC cells 
has allowed a global survey of EC cell genes to be carried out (Kidd et al., 2006).  These 
studies have identified a host of potential sensory transduction components including 
receptors for taste and smell (Kidd et al., 2008), and have opened up the potential for 
comparative studies with diseased tissue (Kidd et al., 2007).   
 
There is a need to re-examine what stimulants cause EC cells to release 5-HT.  Previous 
studies have found many nutrients and other stimuli evoke 5-HT release (Racké et al., 
1996) but whether this was due to a direct effect on the EC cell is not clear.  The genetic 
clues gleaned recently have directed the choice of potential stimulants to be tested while 
the enrichment of EC cells has provided a clear target upon which to test.  Well known 
compounds such as mustard (Nozawa et al., 2009) or caffeine (Kidd et al., 2008), as 
well as odorants found in roses or raspberries (Braun et al., 2007) reliably evoked 5-HT 
release.  Perhaps a more important goal will be to translate these insights into useful 
information about the physiology or pathophysiology of the EC cell.  In this respect, 
electrochemical techniques may be useful as they can provide a continuous readout of 
EC cell activity within whole tissues and during normal function.  The challenge here will 
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be to embed these sensors in the GI tract chronically and to expand the types of sensory 
mediators that they can detect.  In the end, the EC cell is only one of several sub-types 
of EE cell, each with an important role in paracrine signalling.  
 
Conclusions 
The GI tract senses the luminal contents and signals to the extrinsic and intrinsic nerves 
in the wall of the gut.  The EC cell plays a key role in helping to transduce these signals 
by converting chemical, nutrient or mechanical stimuli into the release of 5-HT.  All 
proteins for the production, uptake and degradation of 5-HT are known.  However, many 
exciting new findings have highlighted the role 5-HT plays in disease and uncovered the 
ways in which 5-HT release is controlled.  Proteins once thought specific for taste or 
other sensory transduction systems have been implicated in controlling 5-HT release 
from EC cells.  New techniques have allowed the genetics of enriched EC cells to be 
studied and electrochemical techniques have provided new insight into the kinetics of 5-
HT release.   
  
Acknowledgements 
Kind thanks to Dr Alan Lomax for providing helpful comments on a draft of this 
manuscript.  Financial support came from the School of Medical Sciences (UNSW) and 
the National Health and Medical Research Council (Australia) Grants #510202, #566642 
and #455243. 
Bertrand, PP  5-HT and the gastrointestinal tract 
 Page 23 of 36 
Figure Legends 
Figure 1.  Side view of the intestinal wall showing the different layers.  Top, a 
diagram showing a section of intestine with two villi highlighted and shown in detail 
below.  These layers are, from the top: the mucosal epithelium (EPI) which contains the 
enterocytes and the enteroendocrine (EE) cells - specialised epithelial cells that contain 
neuroactive substances located in secretory granules.  Several types of EE cell are 
depicted (different colours) including the 5-HT containing enterochromaffin (EC) cell 
(depicted releasing 5-HT near to afferent nerve terminals into the underlying lamina 
propria). The submucosal plexus (SMP) is next, with the cell bodies of secretomotor, 
vasodilator, and a population of intrinsic sensory neurons.  The circular muscle (CM), 
followed by the myenteric plexus (MP) which contains the cell bodies of motor neurons, 
interneurons and a population of intrinsic sensory neurons; and finally, the longitudinal 
muscle (LM). 
 
Figure 2.  The production of 5-HT by the enterochromaffin (EC) cell.  A diagram of a 
single EC cell (centre) with surrounding epithelial cells.  The beginning of the synthesis 
pathway for 5-HT is represented at the top of the cell where dietary tryptophan is 
converted to 5-hyroxytryptophan (5-HTP) by the rate-limiting enzyme tryptophan 
hydroxylase 1 (TpH1).  5-HTP is then converted to 5-HT by the enzyme L-amino acid 
decarboxylase (L-AADC).  Newly produced 5-HT is packaged into granules/vesicles by 
the vesicular monoamine transporter 1 (VMAT1).  5-HT is released mainly from the 
granules stored near the basal border of the EC cell (depicted), but studies have also 
identified granules near the apical membrane where release may also take place.  Once 
released, 5-HT can be transported into surrounding epithelial cells by the serotonin 
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reuptake transporter (SERT) and degraded to 5-HIAA by monoamine oxidase A (MAOA; 
located in mitochondria).   
 
Figure 3.  The cycle of 5-HT from the GI tract to liver and general circulation.  Once 
released by the enterochromaffin (EC) cell, there are several possible routes that 5-HT 
may take.  5-HT released into the lumen may escape into the bulk solution (where it can 
be detected in the faeces) or may be taken up by the epithelial cells via the serotonin 
reuptake transporter (SERT).  5-HT released into the lamina propria (where it can 
interact with nerve terminals) may also be taken up into the enterocytes by SERT or may 
enter the blood.  5-HT in the blood is present as free 5-HT or is taken up by platelets via 
SERT.  The portal circulation is first processed by the liver before the blood enters the 
general circulation.  Free 5-HT in the blood is rapidly degraded by MAOA (to 5-HIAA) or 
by glucuronidases, while 5-HT in platelets is protected from degradation.  Thus, under 
normal conditions, only 5-HT stored in platelets enters the general circulation. 
 
Figure 4.  5-HT can be detected selectively in the presence of other transmitters.  
A-C are cyclic voltammetry traces taken with the carbon fibre electrode touching the 
base of an organ bath during equilibration of drugs.  All traces were taken with a scan 
rate of 0.47 V/s and are from the same electrode - background has not been subtracted.  
The bath solution was flushed with fresh physiological saline between panels.  The 
region of the ramp from -350 mV to +920 mV is shown.  The scale in panel C applies to 
all traces and the vertical dotted lines denote the time/voltage at which the peak current 
was produced.  A. Two traces taken with adrenaline (ADR - 40 M) alone (upper) with a 
peak current at +200 mV, and (lower) adrenaline with the addition of 5-HT (0.5 M) with 
a peak current at +360 mV.  B. Melatonin (MEL - 120 M) alone (upper) with a peak 
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current at +710 mV and with the addition of 5-HT (0.5 M; lower) with a peak current at 
+380 mV.  C. Ascorbic acid (AA - 250 M) alone with a peak current at +200 mV (upper) 
and with the addition of 5-HT (0.5 M; lower) with a peak current at +350 mV.  Note that 
oxidation potentials will be offset when different styles of electrochemical electrodes are 
used (e.g., Bian et al., 2007; Patel, 2008). 
 
Figure 5.  Effect of electrode position on 5-HT concentration in guinea pig ileum.  
A. Spontaneous contraction of the circular muscle (CM) and release of 5-HT from guinea 
pig ileum.  In the top traces the electrode was held ~200 m above the mucosal surface.  
Only threshold concentrations of 5-HT were detected (<100 nM).  In the same 
preparation, when the electrode was lowered to within ~100 m, 5-HT concentrations 
more than doubled.  B. Stretch activated release of 5-HT with the electrode in contact 
with the mucosa yielded 10 M 5-HT.  In contrast, with the electrode 200 or 100 m 
away, 5-HT concentrations fell to 200 to 100 nM (traces from A. re-scaled to match the 
scale in B.).   
 
Figure 6.  A comparison of 5-HT levels detected electrochemically near the 
intestinal surface of animal models and human.  'Peak' refers to the peak 
concentration of the compression-evoked 5-HT release.  SS refers to the steady state or 
background levels of 5-HT detected near the surface of the intestinal epithelium.  
Broadly speaking, the levels of compression-evoked 5-HT release varied between 10 
and 25 M while steady state levels varied between 2 and 10 M.  From the left, tissues 
examined were: human sigmoid colon (H-SigC) (Bertrand et al., 2008b); guinea pig 
ileum (GP-Ileum) (Bertrand, 2004, 2006a); mouse ileum (M-Ileum) (Bertrand, 2006b); 
mouse distal colon (M-DC) and mouse dextran sulphate sodium colitis (DSS M-DC) 
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(Bertrand et al., 2008a); rat ileum (R-Ileum) and obese rat ileum (Fat R-Ileum) (Bertrand 
et al., 2008d). 
 
Figure 7.  Overview of how the uptake of 5-HT may affect its actions.  Left: serotonin 
re-uptake transporter (SERT) present in many intestinal epithelial cells. Right: 
enterochromaffin (EC) cell and endogenous 5-HT release. Bottom: nerve terminal from 
the intrinsic and extrinsic sensory nerves containing serotonin receptors, for example the 
5-HT3 receptor.  5-HT released from the EC cell might act directly on the sensory nerve 
terminals and then might be taken up by SERT.  Alternatively, a large proportion of 
released 5-HT might be taken up directly by SERT before it has a chance to act on the 
sensory nerves. Evidence from recent electrochemical studies suggests that small 
amounts of endogenous 5-HT can act directly on the nerve terminal (5-HT3 receptor 
depicted) before being taken up by SERT.  However, 5-HT released in large amounts 
may, in part, be taken up by SERT before acting on the nerve terminals.  A primary role 
of SERT may be to control the background levels of 5-HT.  This is important because 
background levels of 5-HT control the balance between activation and desensitization of 
serotonin receptors. 
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